Yasons Chemex Care Limited (NSE:YCCL)
13.00
0.00 (0.00%)
At close: Jun 20, 2025
Yasons Chemex Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Operating Revenue | 610.91 | 692.43 | 367.73 | 250.52 | 177.74 | 194.1 |
Other Revenue | 2.89 | 2.89 | 20.18 | 0.12 | 0.03 | 0.07 |
Revenue | 613.8 | 695.33 | 387.9 | 250.64 | 177.76 | 194.17 |
Revenue Growth (YoY) | -2.07% | 79.25% | 54.77% | 41.00% | -8.45% | - |
Cost of Revenue | 570.65 | 649.45 | 355.19 | 225.71 | 152.46 | 175.44 |
Gross Profit | 43.15 | 45.88 | 32.71 | 24.93 | 25.3 | 18.73 |
Selling, General & Admin | 10.5 | 8.16 | 1.47 | 1.65 | 0.76 | 1.4 |
Other Operating Expenses | 5.88 | 2.24 | -1.08 | 3.11 | 4.84 | 1.83 |
Operating Expenses | 20.4 | 14.69 | 1.4 | 6.05 | 7.08 | 4.41 |
Operating Income | 22.76 | 31.19 | 31.32 | 18.88 | 18.22 | 14.32 |
Interest Expense | -11.86 | -9.97 | -3.58 | -3.07 | -1.69 | -0.49 |
Interest & Investment Income | 0.12 | 0.12 | 0.58 | 1.97 | 1.88 | 1.98 |
Earnings From Equity Investments | - | - | 14.35 | 8.04 | 0.32 | - |
Currency Exchange Gain (Loss) | 0.03 | 0.03 | - | -0.22 | 0.05 | - |
Other Non Operating Income (Expenses) | -3.33 | -3.33 | -0.53 | -0.49 | -0.62 | -0.04 |
Pretax Income | 7.71 | 18.04 | 42.14 | 25.11 | 18.16 | 15.77 |
Income Tax Expense | 4.65 | 5.57 | 7.86 | 5.57 | 5.63 | 4.22 |
Net Income | 3.06 | 12.48 | 34.28 | 19.54 | 12.54 | 11.55 |
Net Income to Common | 3.06 | 12.48 | 34.28 | 19.54 | 12.54 | 11.55 |
Net Income Growth | -91.40% | -63.60% | 75.41% | 55.89% | 8.52% | - |
Shares Outstanding (Basic) | 18 | 18 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 18 | 18 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | -4.00% | 24.27% | - | - | - | - |
EPS (Basic) | 0.17 | 0.71 | 2.42 | 1.38 | 0.89 | 0.82 |
EPS (Diluted) | 0.17 | 0.71 | 2.42 | 1.38 | 0.89 | 0.82 |
EPS Growth | -91.05% | -70.71% | 75.38% | 55.89% | 8.52% | - |
Free Cash Flow | 19.51 | -162.39 | -2.7 | -0.1 | 20.73 | -5.31 |
Free Cash Flow Per Share | 1.06 | -9.23 | -0.19 | -0.01 | 1.46 | -0.38 |
Gross Margin | 7.03% | 6.60% | 8.43% | 9.95% | 14.24% | 9.65% |
Operating Margin | 3.71% | 4.49% | 8.07% | 7.53% | 10.25% | 7.38% |
Profit Margin | 0.50% | 1.79% | 8.84% | 7.80% | 7.05% | 5.95% |
Free Cash Flow Margin | 3.18% | -23.36% | -0.70% | -0.04% | 11.66% | -2.74% |
EBITDA | 26.77 | 35.48 | 32.33 | 20.18 | 19.71 | 15.5 |
EBITDA Margin | 4.36% | 5.10% | 8.33% | 8.05% | 11.09% | 7.98% |
D&A For EBITDA | 4.01 | 4.29 | 1.01 | 1.29 | 1.49 | 1.18 |
EBIT | 22.76 | 31.19 | 31.32 | 18.88 | 18.22 | 14.32 |
EBIT Margin | 3.71% | 4.49% | 8.07% | 7.53% | 10.25% | 7.38% |
Effective Tax Rate | 60.29% | 30.85% | 18.66% | 22.18% | 30.99% | 26.77% |
Revenue as Reported | 615.82 | 701.99 | 410.06 | 261.7 | 180.48 | 196.16 |
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.